Strong cash flow is vital for a company’s operations, debt payment, and growth. Qualcomm boasts a 15% year-over-year cash flow increase. Gilead Sciences and Exxon Mobil also demonstrate healthy cash flows, supporting dividends. Cash flow is essential for operational success, expansion, and lower bankruptcy risk.

Investors value Qualcomm’s steady cash flow growth, generating $12.8 billion in free cash flow last quarter. Operating cash flow increased significantly due to strong handset and automotive sales. This financial stability positions Qualcomm well for future growth and shareholder returns.

Gilead Sciences, known for antiviral therapies, saw a 20% increase in sales for HIV medication Descovy. The biopharma giant maintains significant cash reserves and flow to continue R&D investment. Gilead’s dividend yield of 2.57% and strong growth potential make it an attractive healthcare sector investment.

Exxon Mobil, the second-largest oil and gas company globally, boasts substantial cash flow despite high capital expenditures. The company’s liquidity and cash flow support operational success, potential expansion, and a longstanding dividend history. Exxon offers a compelling dividend yield of 3.42% and consistent increases over four decades.

Read more at Yahoo Finance: 3 Cash-Flow Machines Investors May Want Heading Into 2026